SHEFFORD HEALTH CENTRE — All Prescriptions & Medications — Page 13
Practice Code: E81033 | SHEFFORD, SG17 5FS
Showing results 601-650 of 728
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ofloxacin | 19 | 532 | £503 | +131.2% ▲ |
| Estradiol valerate | 19 | 1,596 | £132 | -2.7% ▼ |
| Vitamins caps | 19 | 532 | £11 | -65.4% ▼ |
| Ciprofloxain/dexameth | 19 | 105 | £122 | -38.1% ▼ |
| Azelastine hydrochloride | 19 | 418 | £190 | +69.5% ▲ |
| Light liquid paraffin | 19 | 8,650 | £167 | -44.2% ▼ |
| Amorolfine hydrochloride | 19 | 95 | £121 | -17.7% ▼ |
| 19 | 53 | £775 | +37.6% ▲ | |
| Umeclidinium bromide | 18 | 18 | £470 | -70.8% ▼ |
| Cinacalcet hydrochloride | 18 | 504 | £133 | -22.4% ▼ |
| Liquid paraffin | 18 | 8,000 | £86 | +159.5% ▲ |
| Other individually formulated bought in preparations | 18 | 1,426 | £1.5K | -44.9% ▼ |
| Glycopyrronium/formoterol | 17 | 17 | £525 | -32.8% ▼ |
| Sulpiride | 17 | 938 | £78 | -36.5% ▼ |
| Hyoscine | 17 | 262 | £1.7K | +144.9% ▲ |
| Entacapone | 17 | 1,390 | £284 | +11.5% ▲ |
| Mebendazole | 17 | 410 | £24 | +48.5% ▲ |
| Vardenafil | 17 | 104 | £223 | +21.7% ▲ |
| Ciprofloxacin | 17 | 95 | £85 | +113.9% ▲ |
| 17 | 296 | £267 | -47.5% ▼ | |
| 17 | 220 | £575 | +8.3% ▲ | |
| 17 | 510 | £436 | +157.8% ▲ | |
| Darifenacin hydrobromide | 16 | 448 | £404 | -50.9% ▼ |
| Cyproterone acetate | 16 | 532 | £720 | +45.7% ▲ |
| Clindamycin phosphate | 16 | 480 | £77 | -2.7% ▼ |
| Salicylic acid | 16 | 156 | £50 | +26.5% ▲ |
| Hepatitis B | 16 | 16 | £191 | +51.2% ▲ |
| 16 | 780 | £448 | +50.4% ▲ | |
| Chlortalidone | 15 | 502 | £926 | +52.1% ▲ |
| Clindamycin hydrochloride | 15 | 820 | £104 | +49.8% ▲ |
| Glimepiride | 15 | 604 | £18 | -83.7% ▼ |
| Degarelix | 15 | 15 | £1.6K | -13.6% ▼ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 15 | 730 | £2.4K | +51.0% ▲ |
| Tube feed 1.5 kcal/ml (0914011) | 15 | 378.0K | £6.2K | +53.2% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 15 | 515.0K | £11.0K | +56.4% ▲ |
| Benzoyl peroxide | 15 | 1,160 | £158 | +6.4% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 15 | 945 | £123 | +72.9% ▲ |
| 15 | 82 | £768 | +26.0% ▲ | |
| 15 | 15 | £158 | +50.0% ▲ | |
| 15 | 30 | £335 | +14.7% ▲ | |
| 15 | 750 | £140 | -45.1% ▼ | |
| Ciclesonide | 14 | 14 | £257 | -4.9% ▼ |
| Riluzole | 14 | 6,224 | £3.1K | +34.9% ▲ |
| Oestrogens conjugated with progestogen | 14 | 1,148 | £443 | +96.5% ▲ |
| Magnesium aspartate | 14 | 710 | £638 | -7.6% ▼ |
| Timolol and brimonidine | 14 | 70 | £181 | -0.2% vs avg |
| 14 | 120 | £43 | -51.7% ▼ | |
| 14 | 205 | £24 | -47.9% ▼ | |
| Mebeverine hydrochloride compound preparations | 13 | 392 | £343 | +15.0% ▲ |
| Phosphates (Rectal) | 13 | 23 | £270 | +6.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.